Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00890747Phase 1Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myelomonocytic, ChronicPrimary MyelofibrosisRecurrent Adult Acute Myeloid Leukemia+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

John Mascarenhas, MD

Icahn School of Medicine at Mount Sinai

Related
16 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia VeraThrombocythemia, Essential

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Primary MyelofibrosisRecurrent Adult Acute Myeloid LeukemiaRefractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Elias Jabbour

M.D. Anderson Cancer Center

Related
15 trials

Shared therapeutic areas:

Acute Undifferentiated LeukemiaChronic Phase Chronic Myelogenous Leukemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

François Raffi, PHD

Hopital Hotel Dieu Nantes

Related
1 trials

Shared therapeutic areas:

HIV Infections
Similarity Score0%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score0%

Heinz-Josef Lenz, MD

University of Southern California

Related
13 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score0%

Pablo Tebas, MD

University of Pennsylvania

Related
14 trials

Shared therapeutic areas:

HIV Infections
Similarity Score0%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00890747Phase 1PrincipalInvestigator

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
Completed

All 1 trials loaded